Sex and Etiology Differences in Overall Survival and Adverse Liver Events in Hepatocellular Carcinoma: An International Multicenter Study
MedComm · 2026-11 · 7 (11)
DOI: 10.1002/mco2.71048 ↗Abstract
ABSTRACT Sex‐associated differences in hepatocellular carcinoma (HCC) prognosis remain incompletely characterized across major etiologies. In this retrospective international multicenter cohort study, we included 7623 consecutive patients with newly diagnosed HCC from 41 centers in five countries and evaluated the associations of sex and four‐level etiology with overall survival (OS) and the first adverse liver event (hepatic decompensation, liver failure, or liver‐related death). Sex‐related OS was evaluated in the full cohort, after 1:1 propensity‐score matching (1351 men and 1351 women), and in a multivariable Cox model including recorded initial treatment modality; cause‐specific Cox and Fine–Gray models evaluated adverse liver events. Five‐year OS was 24.3% in women and 22.0% in men. Female sex was associated with lower mortality before matching (hazard ratio [HR], 0.90; 95% CI, 0.85–0.97), after matching (HR, 0.91; 95% CI, 0.84–0.99; p = 0.024), and after multivariable adjustment (HR, 0.91; 95% CI, 0.85–0.98; p = 0.010). Male sex was associated with a higher hazard of adverse liver events (cause‐specific HR, 1.26; 95% CI, 1.11–1.43; subdistribution HR [sHR], 1.23; 95% CI, 1.08–1.40). Alcohol‐related and metabolic dysfunction–associated steatotic liver disease (MASLD)‐related HCC had higher liver‐event hazards than hepatitis B virus (HBV)‐related HCC. For OS, the global sex‐by‐etiology interaction was not significant ( p = 0.866). Female sex was associated with modestly better outcomes, although the China‐dominant cohort limits generalizability.
EUVIMED